ClinicalTrials.gg
CompletedNCT06707844Updated Aug 7, 2026

TF and MFR on Calf Muscles in Patients With Pes Planus

An interventional study of Conventional treatment and Myofascial release in Pes Planus, sponsored by Riphah International University. Completed at 1 site in Pakistan. Open to participants aged 18 Years to 25 Years. Per ClinicalTrials.gov, last updated 2026-08-07.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
All
01

Study summary

Pes planus, commonly known as flat feet, is a condition characterized by a reduced or absent arch in the foot, which often leads to pain and functional limitations. This study aims to evaluate the effectiveness of two therapeutic interventions-tissue flossing and myofascial release-in improving balance, arch height, and range of motion (ROM) in patients with flexible flatfoot. The research will be conducted at the Margalla Rehabilitation Center over a duration of six months, involving a total of 44 participants divided into two equal groups. One group will receive tissue flossing as the intervention, while the other group will undergo myofascial release. Participants will be selected using non-probability convenience sampling. Eligible individuals will be adults aged 18-25 years with flexible pes planus and limited ankle dorsiflexion. The study seeks to provide valuable insights into the comparative effectiveness of these interventions for managing symptoms associated with flat feet. Data was be analyzed through SPSS version 25.

Read the detailed description

Pes planus, or flat feet, is characterized by a reduced or absent arch, causing the entire sole to contact the ground. It is categorized into flexible and rigid types, with flexible pes planus being more common. In this form, the arch is visible in non-weight-bearing positions but flattens during standing or walking, while rigid pes planus remains flat irrespective of weight-bearing. The condition often results in foot instability, excessive eversion, and midfoot abduction, leading to pain, fatigue, and reduced shock absorption during activities.

Flexible flatfoot is prevalent in children but can persist into adulthood, affecting 2% to 23% of adults in the U.S. and 13.6% in India. It disrupts gait mechanics, shifting weight medially, impairing balance, and increasing injury risk. Management ranges from conservative treatments like physical therapy to surgical interventions in severe cases.

Emerging therapies include tissue flossing and myofascial release (MFR). Tissue flossing uses compression bands to improve blood flow, reduce pain, and enhance range of motion (ROM). In contrast, MFR applies sustained pressure to relieve fascial tension, promoting flexibility and reducing discomfort. Both techniques show promise for addressing the biomechanical and functional impairments associated with pes planus.

Literature review: According to literature, Galis et al. (2022) performed a study that aimed to examine the effects of applying tissue flossing band at different pressure levels on ankle ROM, strength and power performance in university students. The results showed an increase in dorsiflexion ROM and power. Furthermore, the author concluded that this can aid injury prevention, performance enhancement, and functional ability.

In another study, Driller et al. (2016) conducted a study on the effects of tissue flossing on ankle ROM and jump performance in recreational athletes. The study concluded that applying floss bands to the ankle effectively increased both dorsiflexion and plantarflexion ROM and enhances single-leg jump performance in recreational athletes.

Similarly, Choi et al. (2022) conducted a study aimed at investigating the impact of myofascial release of the peroneus longus muscle on the activity of the abductor hallucis muscle and the medial longitudinal arch in individuals with flexible pes planus. The results showed an increase in abductor hallucis muscle activity and elevation of the medial longitudinal arch.

A study conducted by Chang et al. (2021) examined the effect of a single session of tissue flossing on the knee joint in female college students. The results showed a significant improvement with a medium-to-large effect in the Y-Balance test assessment immediately postintervention. He concluded that tissue flossing can indeed enhance dynamic balance.

02

Conditions studied

  • Pes Planus

Browse trials for

Keywords

  • tissue flossing
  • Flatfeet
  • myofascial release
  • balance
  • arch height
  • range of motion
03

In context

Flatfoot

173 studies on the registry are indexed under Flatfoot; 44 are open to participants now.

This study's enrollment of 44 is close to the median of 40 across 122 interventional studies indexed under Flatfoot.

Browse Flatfoot studies →

Lead sponsor

Riphah International University is the lead sponsor of 2,193 studies on the registry; 650 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18-25 years.
  • Having normal ranging from 18.5 to 24.9 kg/m²
  • Having flexible flat feet, defined as a navicular drop test value of ≥10 mm
  • Must have pain in the calf muscles or ankle joint, with a NPRS score of ≥3
  • Must have limited ankle dorsiflexion ROM, defined as ≤10° of dorsiflexion

Exclusion criteria

Exclusion Criteria:

  • Patients with rigid flatfoot
  • History of ankle or calf muscle injury or surgery within the last 6 months
  • Individuals with latex allergy
  • Individuals having any lumbo-pelvic, hip, knee and ankle pathologies such as fractures, dislocations, degenerative diseases etc.
  • Any neurological disease
  • Pregnant females
  • Individuals with greater than or equal to 25.0 kg/m²
  • Ongoing use of medications such as muscle relaxants or anti-inflammatory drugs
  • Involved in athletic training
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
44 participants (actual)

Study arms

  • Experimental
    Tissue flossing

    * Tissue flossing involves wrapping a latex band around the calf muscles with 50-75% elongation, followed by active ankle movements (dorsiflexion, plantarflexion, circles, heel raises). * Protocol: 4 sets of 8 repetitions, 10-second rest between sets * Performed twice weekly for 3 weeks. Conventional Treatment

    Other: Conventional treatment · Other: Tissue flossing

  • Active comparator
    Myofascial release

    * Myofascial release is a manual therapy applying sustained pressure on the calf muscles to release fascial restrictions. * Protocol: 3 sets of 2-minute pressure applications with a 1-minute break between sets * Performed twice weekly for 3 weeks Conventional Treatment

    Other: Conventional treatment · Other: Myofascial release

Interventions

  • OtherConventional treatment

    Conventional treatment will include: * Stretching exercises (5Reps with 15sec hold): Gastrocnemius-soleus stretch, TA stretch. * Strengthening exercises (5Sets, 5Reps, 5sec hold): Weight-bearing lunges, Short-foot exercise. * Maitland mobilization Grade 2 \& 3 (3 Sets, 20Reps) at Talonavicular joint.

  • OtherMyofascial release

    * Myofascial release is a manual therapy applying sustained pressure on the calf muscles to release fascial restrictions. * Protocol: 3 sets of 2-minute pressure applications with a 1-minute break between sets * Performed twice weekly for 3 weeks

  • OtherTissue flossing

    Tissue flossing involves wrapping a latex band around the calf muscles with 50-75% elongation, followed by active ankle movements (dorsiflexion, plantarflexion, circles, heel raises). Protocol: 4 sets of 8 repetitions, 10-second rest between sets Performed twice weekly for 3 weeks.

06

What researchers measure

Primary outcomes

  1. Numeric Pain Rating Scale (NPRS)

    This tool will be used to assess pain intensity, at baseline, 2nd week and 3rd week post treatment

    Time frame: 3 weeks

Secondary outcomes

  1. Digital Goniometer

    It will be used for the measurement of ankle range of motion. Changes from baseline, 2nd week and 3rd week will be taken.

    Time frame: 3 weeks

  2. Brody's Navicular Drop Test

    It will be used for the measurement of navicular drop. It is the one of the static foot assessment tools and is intended to represent the displacement of the navicular tuberosity from a neutral position. Measurements taken at baseline, 2nd week and 3rd week

    Time frame: 3 weeks

  3. Single-Leg Stance Test

    It will be used to assess each patient's static balance with their eyes open and arms on hips. Good static balance is indicated by participant's ability to maintain position for atleast 30 seconds. Test will be repeated 3 times and average will be taken. measurements will be taken at baseline, 2nd week and 3rd week.

    Time frame: 3 weeks

  4. Y-Balance test

    It will be used for dynamic balance assessment. Patient is asked to stand on one leg while reaching out in 3 different directions (anterior, posteromedial and posterolateral) with the other lower extremity.

    Time frame: 3 weeks

07

Study locations

1 site
  • Margalla Rehabilitation Center
    Rawalpindi, Punjab Province 46000, Pakistan
08

References and documents

Publications

  • 1. R A, Malar A, J H, G S. The cause and frequency of PES Planus (Flat Foot) problems among young adults. Asian Journal of Medical Sciences. 2021;12(7):107-11.

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2025 to primary completion in Aug 2025, 7 months.

Of 89 non-industry interventional studies with no phase under Flatfoot, half reached primary completion within 7 months of starting (the median), counting those still running; a quarter within 2 and three quarters within 15. This study's 7 months is close to that.

Counting every sponsor, half of 89 studies reached it within 7 months; a quarter within 2 and three quarters within 15.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 25, 2024
First posted
Nov 27, 2024
StartActual
Jan 1, 2025
Primary completionActual
Aug 28, 2025
CompletionActual
Aug 29, 2025
Last update
Aug 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06707844
Responsible party
Sponsor
First posted
Nov 27, 2024
Start date
Jan 1, 2025
Primary completion
Aug 28, 2025
Completion
Aug 29, 2025
Last update
Aug 7, 2026

Study contacts

Aneela Zia, MsOMPT
principal investigator · Riphah International University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion